Shufro Rose & CO LLC Organon & Co. Transaction History

Shufro Rose & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$23.31 - $28.61 $137,529 - $168,799	-5,900 Reduced 37.99%	9,630 $0
Q3 2022 Oct 24, 2022	BUY	$23.4 - $34.25 $131,039 - $191,800	5,600 Added 56.39%	15,530 $363,000
Q2 2022 Jul 22, 2022	SELL	$31.66 - $38.9 $26,911 - $33,065	-850 Reduced 7.88%	9,930 $335,000
Q1 2022 May 09, 2022	BUY	$30.45 - $39.36 $328,251 - $424,300	10,780 New	10,780 $377,000
Q4 2021 Jan 27, 2022	SELL	$28.67 - $37.13 $186,068 - $240,973	-6,490 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $37,448 - $46,617	-1,308 Reduced 16.77%	6,490 $213,000
Q2 2021 Jul 28, 2021	BUY	$28.45 - $38.0 $221,853 - $296,324	7,798 New	7,798 $236,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.